Valuation: Beijing SL Pharmaceutical Co., Ltd.

Market Cap 5.43B 812M 722M 669M 609M 1.15B 77.08B 1.17B 8.04B 3.15B 40.23B 3.05B 2.98B 128B P/E 2024
-107x
P/E 2025 -21.7x
Enterprise Value 4.29B 642M 570M 529M 481M 908M 60.9B 922M 6.35B 2.49B 31.78B 2.41B 2.36B 101B EV / Sales 2024
8.62x
EV / Sales 2025 10.3x
Free-Float
59.02%
Yield 2024
0.27%
Yield 2025 0.14%
1 day-0.75%
1 week-8.16%
Current month-8.00%
1 month-5.03%
3 months-19.36%
6 months-33.12%
Current year-28.22%
1 week 5.22
Extreme 5.22
5.82
1 month 5.22
Extreme 5.22
5.99
Current year 4.81
Extreme 4.81
9.4
1 year 4.81
Extreme 4.81
9.4
3 years 4.81
Extreme 4.81
15.93
5 years 4.81
Extreme 4.81
16.09
10 years 4.81
Extreme 4.81
33.03
Manager TitleAgeSince
Chief Executive Officer 62 11/04/2006
Corporate Secretary 60 11/04/2006
Director TitleAgeSince
Chairman 62 11/04/2006
Director/Board Member 60 24/04/2009
Chairman 56 28/05/2015
Date Insider Type Main position Quantity % Market Cap. Importance
5/11/25 Buy

Director

100 0.0000%
29/10/25 Sell

Director

35,100 0.0041%
28/10/25 Sell

Director

340,000 0.0399%
Change 5-day change 1-year change 3-year change Capi.($)
-0.75%-8.16%-28.22%-63.84% 818M
+0.43%+6.59%+53.41%+103.85% 1,116B
+0.90%-2.25%+33.02%+62.23% 610B
+0.71%+3.24%+25.81%+93.86% 501B
-0.13%+5.98%+32.91%+50.39% 366B
+0.52%+0.24%+73.92%+40.15% 358B
-0.95%+4.70%+19.51%+43.00% 288B
-1.98%+3.73%-0.86%+13.43% 261B
-0.35%+4.25%+46.21%+50.76% 235B
-0.75%+3.32%+32.53%+97.21% 195B
Average -0.23%+3.08%+28.82%+49.10% 393.06B
Weighted average by Cap. +0.13%+4.16%+39.12%+71.33%

Financials

2024 2025
Net sales 660M 98.7M 87.73M 81.32M 73.99M 140M 9.37B 142M 977M 383M 4.89B 370M 363M 15.58B 624M 93.2M 82.85M 76.79M 69.87M 132M 8.85B 134M 923M 362M 4.62B 350M 342M 14.72B
Net income -74.07M -11.07M -9.84M -9.12M -8.3M -15.66M -1.05B -15.91M -110M -42.98M -548M -41.54M -40.66M -1.75B -347M -51.89M -46.12M -42.75M -38.9M -73.4M -4.92B -74.57M -514M -201M -2.57B -195M -191M -8.19B
Net Debt -1.98B -296M -263M -244M -222M -419M -28.12B -426M -2.93B -1.15B -14.67B -1.11B -1.09B -46.77B -1.14B -171M -152M -141M -128M -241M -16.19B -245M -1.69B -662M -8.45B -640M -627M -26.93B
Projected Income Statement - Annual - Beijing SL Pharmaceutical Co., Ltd.
Logo Beijing SL Pharmaceutical Co., Ltd.
Beijing SL Pharmaceutical Co., Ltd. specializes in manufacturing and marketing medicines produced by genetic engineering. Products are primarily for treating neutropenia, thrombocytopenia, renal cancer, melanoma and chronic skin ulcer.
Employees
901
Date Price Change Volume
16/10/26 CNY 5.290 -0.75% 25,832,172
15/10/26 CNY 5.330 -2.02% 17,330,793
14/10/26 CNY 5.440 -1.27% 11,207,317
13/10/26 CNY 5.510 -1.78% 24,175,298
12/10/26 CNY 5.610 -2.60% 17,201,664

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Beijing SL Pharmaceutical Co., Ltd.
  1. Stock Market
  2. Stocks
  3. 002038 Stock